These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33554314)

  • 1. Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC.
    Yoon H; Ha S; Kwon SJ; Park SY; Kim J; O JH; Yoo IR
    Ann Nucl Med; 2021 Mar; 35(3):370-377. PubMed ID: 33554314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of the
    Wakisaka R; Kumai T; Komatsuda H; Yamaki H; Kono M; Sato R; Ohara K; Kishibe K; Hayashi T; Okizaki A; Takahara M
    Clin Otolaryngol; 2024 Nov; 49(6):733-741. PubMed ID: 38950901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment
    Liu Z; Cao Y; Diao W; Cheng Y; Jia Z; Peng X
    Aging (Albany NY); 2020 Jul; 12(14):14593-14619. PubMed ID: 32674074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.
    Creff G; Devillers A; Depeursinge A; Palard-Novello X; Acosta O; Jegoux F; Castelli J
    JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):471-479. PubMed ID: 32215611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of
    Song Y; Tian Y; Lu X; Chen G; Lv X
    Med Phys; 2024 Jul; 51(7):4907-4921. PubMed ID: 38252704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with
    Risør LM; Clausen MM; Ujmajuridze Z; Farhadi M; Andersen KF; Loft A; Friborg J; Kjaer A
    J Nucl Med; 2022 Aug; 63(8):1169-1176. PubMed ID: 34857658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Significance of Tumor SUVmax Value in Pre- and Post-Chemoradiotherapy 18F-FDG PET/CT Imaging in Patients with Localized and Advanced Head and Neck Squamous Cell Carcinoma.
    Kandemir O; Demir F; Avcı GG
    Niger J Clin Pract; 2024 Jun; 27(6):748-753. PubMed ID: 38943299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
    Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
    Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between DW-MRI and
    Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
    Zschaeck S; Löck S; Leger S; Haase R; Bandurska-Luque A; Appold S; Kotzerke J; Zips D; Richter C; Gudziol V; Schreiber A; Zöphel K; Baumann M; Krause M
    Radiother Oncol; 2017 Mar; 122(3):437-444. PubMed ID: 28222892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of volumetric 4'-[methyl-
    Hoshikawa H; Mori T; Maeda Y; Takahashi S; Ouchi Y; Yamamoto Y; Nishiyama Y
    Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of
    Combet-Curt V; Buchalet C; Le Malicot K; Lemanski C; Deshayes E; Bonichon-Lamichhane N; Lièvre A; Huguet F; Tlili G; Vendrely V
    J Nucl Med; 2024 Aug; 65(8):1194-1201. PubMed ID: 38936973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of FDG-PET/CT parameters for the assessment of the immune status in advanced HNSCC.
    Ohashi T; Terasawa K; Aoki M; Akazawa T; Shibata H; Kuze B; Asano T; Kato H; Miyazaki T; Matsuo M; Inoue N; Ito Y
    Auris Nasus Larynx; 2020 Aug; 47(4):658-667. PubMed ID: 32089351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of clinical and
    Cho JK; Hyun SH; Choi JY; Choi N; Kim MJ; Lee SH; Baek KH; Jeong HS
    J Surg Oncol; 2016 Dec; 114(7):888-894. PubMed ID: 27546387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
    Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 years.
    Paidpally V; Tahari AK; Lam S; Alluri K; Marur S; Koch W; Wahl RL; Subramaniam RM
    J Nucl Med; 2013 Dec; 54(12):2039-45. PubMed ID: 24101687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.